UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Venturi Wealth Management LLC

Venturi Wealth Management LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 31,753 shares of the healthcare conglomerate's stock after acquiring an additional 2,770 shares during the period. Venturi Wealth Management LLC's holdings in UnitedHealth Group were worth $16,063,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $30,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter valued at approximately $37,000. DecisionPoint Financial LLC grew its holdings in shares of UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock worth $52,000 after acquiring an additional 62 shares during the period. Highline Wealth Partners LLC acquired a new position in UnitedHealth Group during the third quarter worth $55,000. Finally, Legacy Investment Solutions LLC acquired a new stake in UnitedHealth Group in the third quarter valued at $57,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 7.3 %

NYSE UNH traded down $36.84 during mid-day trading on Friday, hitting $465.58. The company's stock had a trading volume of 19,847,353 shares, compared to its average volume of 4,805,500. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The stock's fifty day simple moving average is $519.27 and its two-hundred day simple moving average is $560.54. The firm has a market capitalization of $428.46 billion, a P/E ratio of 30.04, a price-to-earnings-growth ratio of 1.40 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm's revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the company earned $5.83 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business's stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.33% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on UNH shares. Barclays decreased their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research report on Friday, January 17th. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. KeyCorp reaffirmed an "overweight" rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Piper Sandler reduced their price objective on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research report on Thursday, January 2nd. Finally, Cantor Fitzgerald reissued an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Buy" and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.